13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001475373
申报总市值
US$4.6亿
US$4.6亿
41 檔
29.2%
Sector Gamma As 在 Q3 2025 季度的美股仓位总计估值为 US$4.6亿，分散于 41 个持仓标的之中，反映其市场参与广度与投资规模。
在 Q3 2025，Sector Gamma As 操作展现出积极扩展与加仓意向。本季共新建仓 12 个新仓位，并对 19 个既有持股进行加仓（合计增持 31 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Sector Gamma As 的前 5 大核心持股（包含 PFE, MDT, MRK 等）合计占整体申报市值的 29.2%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PFE | Pfizer Inc | 股票-医疗保健 | 7.91% | -1.99% | +36.10% | |
| 2 | MDT | Medtronic plc | 股票-医疗保健 | 7.17% | +0.24% | +35.46% | |
| 3 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 6.71% | -1.34% | +59.65% | |
| 4 | BMY | Bristol-myers Squibb Co | 股票-医疗保健 | 6.50% | -2.78% | +43.17% | |
| 5 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 5.05% | -0.01% | +11.05% | |
| 6 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 4.40% | +0.26% | -5.21% | |
| 7 | INCY | Incyte CORP | 股票-医疗保健 | 4.31% | -0.26% | +0.55% | |
| 8 | AMGN | Amgen Inc | 股票-医疗保健 | 4.30% | -1.86% | +39.67% | |
| 9 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 4.05% | -1.75% | EXIT | |
| 10 | CVS | Cvs Health CORP | 股票-医疗保健 | 2.92% | +1.19% | -4.17% | |
| 11 | ZBH | Zimmer Biomet Holdings Inc | 股票-医疗保健 | 2.77% | -0.67% | +28.03% | |
| 12 | BIIB | Biogen Inc | 股票-医疗保健 | 2.62% | -1.36% | +49.05% | |
| 13 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 2.36% | +0.46% | +43.73% | |
| 14 | CAH | Cardinal Health Inc | 股票-医疗保健 | 2.32% | -0.64% | -9.79% | |
| 15 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 2.22% | +3.65% | NEW | |
| 16 | BAX | Baxter International Inc | 股票-医疗保健 | 2.15% | — | +42.37% | |
| 17 | GEHC | GE Healthcare Technology | 股票-医疗保健 | 2.07% | +0.77% | +50.53% | |
| 18 | BRKR | Bruker CORP | 股票-医疗保健 | 2.02% | -0.18% | +28.03% | |
| 19 | CNC | Centene CORP | 股票-医疗保健 | 1.89% | +1.00% | +40.27% | |
| 20 | LH | Labcorp Holdings Inc | 股票-医疗保健 | 1.85% | +0.38% | +33.29% | |
| 21 | PTCT | Ptc Therapeutics Inc | 股票-医疗保健 | 1.80% | +0.56% | +28.03% | |
| 22 | VTRS | Viatris Inc | 股票-医疗保健 | 1.64% | — | — | |
| 23 | BIO | Bio-rad Laboratories-a | 股票-医疗保健 | 1.59% | +0.56% | +28.03% | |
| 24 | HUM | Humana Inc | 股票-医疗保健 | 1.54% | -0.79% | EXIT | |
| 25 | ELAN | Elanco Animal Health Inc | 股票-医疗保健 | 1.53% | — | +5.20% | |
| 26 | AVTR | Avantor Inc | 股票-医疗保健 | 1.48% | +0.66% | +28.03% | |
| 27 | OGN | Organon & Co | 股票-医疗保健 | 1.44% | +0.27% | — | |
| 28 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.41% | +0.05% | +73.76% | |
| 29 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.28% | +0.66% | +53.64% | |
| 30 | ASND | Ascendis Pharma A/S | 股票-其他 | 1.20% | -1.15% | EXIT | |
| 31 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 1.15% | — | +36.04% | |
| 32 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 1.08% | — | — | |
| 33 | SOLV | Solventum CORP | 股票-医疗保健 | 1.07% | — | +55.94% | |
| 34 | KURA | Kura Oncology Inc | 股票-其他 | 0.96% | +0.24% | — | |
| 35 | LNTH | Lantheus Holdings Inc | 股票-医疗保健 | 0.82% | -1.67% | EXIT | |
| 36 | TNDM | Tandem Diabetes Care Inc | 股票-其他 | 0.81% | -0.34% | +28.03% | |
| 37 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 0.80% | -0.43% | — | |
| 38 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.77% | +0.69% | -48.86% | |
| 39 | CERT | Certara Inc | 股票-其他 | 0.70% | — | — | |
| 40 | BNTX | Biontech Se-adr | 股票-其他 | 0.68% | — | -25.99% | |
| 41 | ACLXGBX | Arcellx Inc | 股票-其他 | 0.65% | — | +28.04% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | BIIB | Biogen Inc | +1.8% | +49.05% | 加仓 |
| 2 | IONS | Ionis Pharmaceuticals Inc | +1.6% | -5.21% | 减仓 |
| 3 | MDT | Medtronic plc | +1.3% | +35.46% | 加仓 |
| 4 | INCY | Incyte CORP | +1.2% | +0.55% | 加仓 |
| 5 | BIO | Bio-rad Laboratories-a | +0.5% | +28.03% | 加仓 |
| 6 | GEHC | GE Healthcare Technology | +0.5% | +50.53% | 加仓 |
| 7 | PFE | Pfizer Inc | +0.4% | +36.10% | 加仓 |
| 8 | ASND | Ascendis Pharma A/S | +0.4% | +43.10% | 加仓 |
| 9 | SOLV | Solventum CORP | +0.3% | +55.94% | 加仓 |
| 10 | PTCT | Ptc Therapeutics Inc | +0.3% | +28.03% | 加仓 |
| 11 | LNTH | Lantheus Holdings Inc | 0% | +28.04% | 加仓 |
| 12 | ELAN | Elanco Animal Health Inc | -0.1% | +5.20% | 减仓 |
| 13 | ACLXGBX | Arcellx Inc | -0.1% | +28.04% | 减仓 |
| 14 | BNTX | Biontech Se-adr | -0.2% | -25.99% | 减仓 |
| 15 | TNDM | Tandem Diabetes Care Inc | -0.3% | +28.03% | 加仓 |
| 16 | BAX | Baxter International Inc | -0.6% | +42.37% | 加仓 |
| 17 | HUM | Humana Inc | -0.6% | +1.88% | 减仓 |
| 18 | BMRN | Biomarin Pharmaceutical Inc | -0.8% | +43.73% | 加仓 |
| 19 | BRKR | Bruker CORP | -0.8% | +28.03% | 加仓 |
| 20 | BDX | Becton Dickinson And Co | -1% | +11.05% | 加仓 |
| 21 | GILD | Gilead Sciences Inc | -1% | +15.94% | 加仓 |
| 22 | ZBH | Zimmer Biomet Holdings Inc | -1.4% | +28.03% | 减仓 |
| 23 | EW | Edwards Lifesciences CORP | -1.5% | +73.76% | 减仓 |
| 24 | CVS | Cvs Health CORP | -1.5% | -4.17% | 减仓 |
| 25 | CNC | Centene CORP | -1.6% | +40.27% | 加仓 |
| 26 | CAH | Cardinal Health Inc | -1.6% | -9.79% | 减仓 |
| 27 | AMGN | Amgen Inc | -1.6% | +39.67% | 加仓 |
| 28 | BMY | Bristol-myers Squibb Co | -2% | +43.17% | 加仓 |
| 29 | ELV | Elevance Health Inc | -3.2% | -48.86% | 减仓 |
| 30 | MRK | Merck & Co. Inc. | — | NEW | 新建仓 |
| 31 | JNJ | Johnson & Johnson | — | EXIT | 清仓 |
| 32 | TMO | Thermo Fisher Scientific Inc | — | NEW | 新建仓 |
| 33 | QGEN | Qiagen N.V. | — | EXIT | 清仓 |
| 34 | LH | Labcorp Holdings Inc | — | NEW | 新建仓 |
| 35 | VTRS | Viatris Inc | — | NEW | 新建仓 |
| 36 | AVTR | Avantor Inc | — | NEW | 新建仓 |
| 37 | OGN | Organon & Co | — | NEW | 新建仓 |
| 38 | THC | Tenet Healthcare CORP | — | EXIT | 清仓 |
| 39 | DXCM | Dexcom Inc | — | NEW | 新建仓 |
| 40 | HCA | Hca Healthcare Inc | — | NEW | 新建仓 |
| 41 | ICLR | ICON Public Limited Company | — | NEW | 新建仓 |
| 42 | KURA | Kura Oncology Inc | — | NEW | 新建仓 |
| 43 | SNDX | Syndax Pharmaceuticals Inc | — | NEW | 新建仓 |
| 44 | CERT | Certara Inc | — | NEW | 新建仓 |
| 45 | TGTX | Tg Therapeutics Inc | — | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Sector Gamma As 在 Q3 2025 季度的美股持仓总市值约为 US$4.6亿，共申报了 41 个公开持股仓位。
在 Q3 2025 季度，Sector Gamma As 按市值排列的前三大核心持股分别为：PFE (7.9%)、MDT (7.2%)、MRK (6.7%)。其中最大持股仓位 PFE 占据整体投资组合约 7.9% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
MRK
市值: US$2706.7万
本季最大获利了结 / 清仓标的
JNJ
前期市值: US$1625.2万
在 Q3 2025 季度中，Sector Gamma As 共进行了 45 项持仓异动，包含新建仓 12 个仓位、加仓 19 个仓位、减仓 10 个仓位以及清仓 4 个仓位。 其中最大新建仓标的为 MRK。 本季清仓仓位包含 JNJ。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。